98 related articles for article (PubMed ID: 3113728)
1. Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits.
Gordon IL; Kar R; Opfell RW; Wile AG
Cancer Res; 1987 Oct; 47(19):5070-3. PubMed ID: 3113728
[TBL] [Abstract][Full Text] [Related]
2. Parenteral formulation of hexamethylmelamine potentially suitable for use in man.
Ames MM; Kovach JS
Cancer Treat Rep; 1982 Jul; 66(7):1579-81. PubMed ID: 6807543
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicle.
Wickes AD; Howell SB
Cancer Treat Rep; 1985 Jun; 69(6):657-62. PubMed ID: 3926309
[TBL] [Abstract][Full Text] [Related]
4. Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
Klippert PJ; Hulshoff A; Mingels MJ; Hofman G; Noordhoek J
Cancer Res; 1983 Jul; 43(7):3160-4. PubMed ID: 6406053
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
Ames MM; Powis G; Kovach JS; Eagan RT
Cancer Res; 1979 Dec; 39(12):5016-21. PubMed ID: 115586
[TBL] [Abstract][Full Text] [Related]
7. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
[TBL] [Abstract][Full Text] [Related]
8. Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.
Ames MM; Richardson RL; Kovach JS; Moertel CG; O'Connell MJ
Cancer Res; 1990 Jan; 50(1):206-10. PubMed ID: 2104537
[TBL] [Abstract][Full Text] [Related]
9. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
10. Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.
Broggini M; Rossi C; Colombo T; D'Incalci M
Cancer Treat Rep; 1982 Jan; 66(1):127-33. PubMed ID: 6796267
[TBL] [Abstract][Full Text] [Related]
11. Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine.
Paolini A; D'Incalci M
Cancer Treat Rep; 1986 Apr; 70(4):513-6. PubMed ID: 3084083
[TBL] [Abstract][Full Text] [Related]
12. Liver lipid composition and intravenous, intraperitoneal, and enteral administration of intralipid.
Morán Penco JM; Maciá Botejara E; Salas Martinez J; Mahedero Ruiz G; Climent Mata V; Saenz de Santamaria J; Vinagre Velasco LM
Nutrition; 1994; 10(1):26-31. PubMed ID: 8199419
[TBL] [Abstract][Full Text] [Related]
13. Hexamethylmelamine distribution in patients with ovarian and other pelvic cancers.
D'Incalci M; Farina P; Sessa C; Mangioni C; Garattini S
Cancer Treat Rep; 1982 Feb; 66(2):231-5. PubMed ID: 6799199
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 5-fluorouracil following different routes of intrahepatic administration in the canine model.
Didolkar MS; Covell DG; Jackson AJ; Walker AP; Kalidindi SR
Cancer Res; 1984 Nov; 44(11):5105-9. PubMed ID: 6488170
[TBL] [Abstract][Full Text] [Related]
15. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
16. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamine.
Brindley C; Gescher A; Langdon SP; Broggini M; Colombo T; D'Incalci M
Biochem Pharmacol; 1982 Mar; 31(5):625-31. PubMed ID: 6805472
[TBL] [Abstract][Full Text] [Related]
18. Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
Foster BJ; Clagett-Carr K; Marsoni S; Simon R; Leyland-Jones B
Cancer Treat Rep; 1986 Aug; 70(8):1003-14. PubMed ID: 3089597
[TBL] [Abstract][Full Text] [Related]
19. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
[TBL] [Abstract][Full Text] [Related]
20. Role of N-methylolpentamethylmelamine in the metabolic activation of hexamethylmelamine.
Ames MM; Sanders ME; Tiede WS
Cancer Res; 1983 Feb; 43(2):500-4. PubMed ID: 6401219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
